Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers
Status:
Completed
Trial end date:
2014-12-31
Target enrollment:
Participant gender:
Summary
This is a phase I, open-label, randomized, 5 period, crossover, single-center trial. The
purpose of this trial is to assess the relative bio-availability of L-praziquantel (L-PZQ
[MSC2499550A]) oral dispersible tablet (ODT) formulation (150 milligram [mg]) versus the
current marketed racemate praziquantel (PZQ) (Cysticide® 500 mg) formulation in healthy male
volunteers under fed conditions.